FI802917A - Hybridcellinje foer framstaellning av en monoklonal antikropp foer maenskliga cytotoxiska och supressor-t-celler antikropp och foerfarande - Google Patents

Hybridcellinje foer framstaellning av en monoklonal antikropp foer maenskliga cytotoxiska och supressor-t-celler antikropp och foerfarande

Info

Publication number
FI802917A
FI802917A FI802917A FI802917A FI802917A FI 802917 A FI802917 A FI 802917A FI 802917 A FI802917 A FI 802917A FI 802917 A FI802917 A FI 802917A FI 802917 A FI802917 A FI 802917A
Authority
FI
Finland
Prior art keywords
antikropp
och
maenskliga
celler
supressor
Prior art date
Application number
FI802917A
Other languages
English (en)
Other versions
FI75364B (fi
FI75364C (fi
Inventor
Patrick Chung-Shu Kung
Gideon Goldstein
Original Assignee
Ortho Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26758322&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI802917(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ortho Pharma Corp filed Critical Ortho Pharma Corp
Publication of FI802917A publication Critical patent/FI802917A/fi
Priority to FI844706A priority Critical patent/FI75231C/fi
Publication of FI75364B publication Critical patent/FI75364B/fi
Application granted granted Critical
Publication of FI75364C publication Critical patent/FI75364C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/948Microorganisms using viruses or cell lines
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806Antigenic peptides or proteins
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/808Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/808Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
    • Y10S530/809Fused cells, e.g. hybridoma
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/868Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving autoimmunity, allergy, immediate hypersensitivity, delayed hypersensitivity, immunosuppression, or immunotolerance

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
FI802917A 1979-09-18 1980-09-17 Foerfarande foer framstaellning av en monoklonal antikropp foer maenskliga cytotoxiska och suppressor-t-celler medelst en ny hybridcellinje. FI75364C (fi)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FI844706A FI75231C (fi) 1979-09-18 1984-11-29 Diagnostiskt foerfarande vid vilket anvaends en monoklonal antikropp specifik mot maenniskans cytotoxiska och supressor-t-celler.

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US7664279A 1979-09-18 1979-09-18
US7664279 1979-09-18
US06/082,515 US4364932A (en) 1979-09-18 1979-10-09 Monoclonal antibody to human cytotoxic and suppressor T cells and methods of preparing same
US8251579 1979-10-09

Publications (3)

Publication Number Publication Date
FI802917A true FI802917A (fi) 1981-03-19
FI75364B FI75364B (fi) 1988-02-29
FI75364C FI75364C (fi) 1988-06-09

Family

ID=26758322

Family Applications (1)

Application Number Title Priority Date Filing Date
FI802917A FI75364C (fi) 1979-09-18 1980-09-17 Foerfarande foer framstaellning av en monoklonal antikropp foer maenskliga cytotoxiska och suppressor-t-celler medelst en ny hybridcellinje.

Country Status (19)

Country Link
US (1) US4364932A (fi)
EP (1) EP0025722B2 (fi)
AU (1) AU537806B2 (fi)
CA (1) CA1170593A (fi)
DE (2) DE3070669D1 (fi)
DK (1) DK154566C (fi)
ES (1) ES495165A0 (fi)
FI (1) FI75364C (fi)
GR (1) GR70286B (fi)
HK (1) HK23986A (fi)
IE (1) IE50534B1 (fi)
IL (1) IL61063A (fi)
MY (1) MY8600515A (fi)
NO (1) NO159884C (fi)
NZ (1) NZ194982A (fi)
PH (1) PH16567A (fi)
PT (1) PT71814B (fi)
SG (1) SG6386G (fi)
YU (1) YU44411B (fi)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4637983A (en) * 1979-10-09 1987-01-20 Ortho Pharmaceutical Corporation Hybrid cell line for producing monoclonal antibody to human cytotoxic and suppressor T cells, antibody, and methods
US4803262A (en) * 1979-10-09 1989-02-07 Ortho Pharmaceutical Corporation Hybrid cell line for producing monoclonal antibody to human cytotoxic and suppressor T cells, antibody, and methods
USRE32011E (en) * 1981-12-14 1985-10-22 Scripps Clinic And Research Foundation Ultrapurification of factor VIII using monoclonal antibodies
US4511662A (en) * 1982-06-18 1985-04-16 Bio-Rad Laboratories, Inc. Simultaneous assay for T and B lymphocyte populations and subpopulations
US4443427A (en) * 1982-06-21 1984-04-17 Sidney Farber Cancer Institute, Inc. Monoclonal antibody
US4524025A (en) * 1982-06-30 1985-06-18 E. I. Du Pont De Nemours And Company Hybridoma cell lines and monoclonal antibodies to theophylline
US4579827A (en) * 1983-03-11 1986-04-01 Sloan-Kettering Institute For Cancer Research Monoclonal antibodies to human gastrointestinal cancers and hybridoma method of production of the monoclonal antibodies
US4677056A (en) * 1983-08-18 1987-06-30 Sloan-Kettering Institute For Cancer Research Monoclonal antibody subsetting human helper and killer T-cells and method
US4965204A (en) * 1984-02-06 1990-10-23 The Johns Hopkins University Human stem cells and monoclonal antibodies
US5130144B1 (en) * 1984-02-06 1995-08-15 Univ Johns Hopkins Human stem cells and monoclonal antibodies
FR2560212B1 (fr) * 1984-02-24 1989-12-29 Unicet Anticorps monoclonaux contre l'interferon a2 et hybridomes produisant de tels anticorps
US4649106A (en) * 1984-06-01 1987-03-10 Dana-Farber Cancer Institute, Inc. Distinguishing subsets of human cells
JPS6179164A (ja) * 1984-09-26 1986-04-22 Amano Pharmaceut Co Ltd 抗原抗体反応の短縮方法
US5431897A (en) * 1985-04-19 1995-07-11 Sloan-Kettering Institute For Cancer Research Method of imaging colorectal carcinoma lesion and composition for use therein
WO1987006610A1 (en) * 1986-04-28 1987-11-05 Endotronics, Inc. Method of culturing leukocytes
US4970299A (en) * 1986-07-03 1990-11-13 Sloan-Kettering Institute For Cancer Research Monoclonal antibodies selective for prostate cancer
US5085985A (en) * 1987-11-12 1992-02-04 Becton Dickinson & Co. Monoclonal antibodies and their use in a method for monitoring subsets of activated T cells
US5601819A (en) * 1988-08-11 1997-02-11 The General Hospital Corporation Bispecific antibodies for selective immune regulation and for selective immune cell binding
WO1999025734A2 (en) * 1997-11-13 1999-05-27 Schering Corporation Th2 CELL DEPLETION; COMPOSITIONS; METHODS
AU1539699A (en) * 1997-11-24 1999-06-15 Johnson T. Wong Methods for treatment of hiv or other infections using a t cell or viral activator and anti-retroviral combination therapy
US7653260B2 (en) 2004-06-17 2010-01-26 Carl Zeis MicroImaging GmbH System and method of registering field of view
US8582924B2 (en) 2004-06-30 2013-11-12 Carl Zeiss Microimaging Gmbh Data structure of an image storage and retrieval system

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4196265A (en) * 1977-06-15 1980-04-01 The Wistar Institute Method of producing antibodies
US4172124A (en) * 1978-04-28 1979-10-23 The Wistar Institute Method of producing tumor antibodies
US4284412A (en) * 1979-07-13 1981-08-18 Ortho Diagnostics, Inc. Method and apparatus for automated identification and enumeration of specified blood cell subclasses

Also Published As

Publication number Publication date
DE3070669D1 (en) 1985-06-27
PH16567A (en) 1983-11-18
HK23986A (en) 1986-04-11
EP0025722A2 (en) 1981-03-25
IL61063A0 (en) 1980-11-30
NO159884B (no) 1988-11-07
EP0025722B1 (en) 1985-05-22
ES8200559A1 (es) 1981-11-16
PT71814A (en) 1980-10-01
EP0025722A3 (en) 1981-11-04
GR70286B (fi) 1982-09-03
YU44411B (en) 1990-08-31
NZ194982A (en) 1983-02-15
IE50534B1 (en) 1986-05-14
DK394880A (da) 1981-03-19
AU537806B2 (en) 1984-07-12
NO802751L (no) 1981-03-19
PT71814B (en) 1982-03-26
ES495165A0 (es) 1981-11-16
FI75364B (fi) 1988-02-29
IE801944L (en) 1981-03-18
AU6247680A (en) 1981-04-09
DK154566B (da) 1988-11-28
IL61063A (en) 1984-04-30
CA1170593A (en) 1984-07-10
NO159884C (no) 1989-02-15
FI75364C (fi) 1988-06-09
EP0025722B2 (en) 1999-04-14
SG6386G (en) 1986-11-21
YU239280A (en) 1984-04-30
DK154566C (da) 1989-04-17
MY8600515A (en) 1986-12-31
US4364932A (en) 1982-12-21
DE25722T1 (de) 1984-07-19

Similar Documents

Publication Publication Date Title
FI802917A (fi) Hybridcellinje foer framstaellning av en monoklonal antikropp foer maenskliga cytotoxiska och supressor-t-celler antikropp och foerfarande
FI802720A (fi) Beta-karbolin-3-karboxylsyraderivat och foerfaranden foer framstaellning av dem
FI803340L (fi) Foerfarande och anordning foer skyddande av en bioreaktors under tryck varande tryckbehaollare mot ytterst stora svallningar av instroemmande avfallsvatten
IT1132532B (it) Fosfodiesteri di nucleosidi-corticosteroidi citotossici
FI802065A (fi) Foerfarande och anordning foer aostadkommande av en aendfoerslutning pao ett veckat stycke slangmaterial speciellt konsttarm foer korvframstaellning
FI801748A (fi) Saett och anordning foer avstaondsmaetning
FI793637A (fi) Anordning foer lagring av sjaelvupphettande radioaktiva aemnen
FI791914A (fi) Foerfarande och anordning foer behandling av gasformiga foerbraenningsprodukter
FI803531L (fi) Foerfarande foer framstaellning av ett i vatten dispergerbart naeringsbasmedel
FI800701A (fi) Foerfarande och anordning foer belaeggning av ett filmartat aemne saerskilt en pappers- eller kartongbana
FI801125A (fi) Anordning foer infoering av en materialbana i en behandlingsanlaeggning
FI801739A (fi) Anordning foer saogning av olika material
NO802932L (no) Polboessing for batterier
FI792738A (fi) Foerfaringssaett foer infoerande av en kabel i en vulkaniseringskammare och anordning foer utfoerande av foerfarandet
SE7904987L (sv) Hallare for vermeror
FI802093A (fi) Isokinolinderivat innehaollande svavel ett foerfarande foer deras framstaellning och farmaceutiska sammansaettningar innehaollande dessa
FI790105A (fi) Foerfarande och anordning foer behandling av fiberbana
FI800083A (fi) Saett och anordning foer hantering av saeckar saerskilt papperssaeckar
SE8003894L (sv) Fotoglor for segelbredor
NO802372L (no) Fremgangsmaate for fremstilling av 2-isopropylamino-pyrimidin
FI793250A (fi) Foerfarande och anordning foer lastning av bytesflak
FI793525A (fi) Foerfarande foer transportering av flyttbart flak och flyttbart flak
FI803861L (fi) Anordning foer magnetisering av konvergensutrustning foer inlinefaergbildroer och foerfarande foer konvergensinstaellning medelst denna anordning
IT1174304B (it) Procedimento per produrre polietilene
FI65449B (fi) Foerfarand ramstaellning av ett titangarvmedel och foerfarande foer garvning av laeder under anvaendning av titangarvmedel

Legal Events

Date Code Title Description
MA Patent expired

Owner name: ORTHO PHARMACEUTICAL CORPORATION